This week Merck announced that long-tenured executive Ken Frazier will retire from the company on November 30 when he steps down as executive chairman of the company’s board.
Frazier became executive chairman last year following his decade-long stint as president/chief executive. Rob Davis, Merck’s current president and CEO, is slated to become board chairman December 1.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,